Medtronic plc. (MDT)

NYSE: MDT · IEX Real-Time Price · USD
107.53 -1.02 (-0.94%)
Jan 18, 2022 2:43 PM EST - Market open
Market Cap144.57B
Revenue (ttm)31.80B
Net Income (ttm)4.70B
Shares Out1.34B
EPS (ttm)3.47
PE Ratio31.00
Forward PE19.69
Dividend$2.47 (2.30%)
Ex-Dividend DateDec 21, 2021
Volume4,171,247
Open107.01
Previous Close108.55
Day's Range106.32 - 108.21
52-Week Range98.38 - 135.89
Beta0.81
AnalystsBuy
Price Target131.64 (+22.4%)
Earnings Daten/a

About MDT

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX product...

IndustryHealth Care Equipment & Supplies
Founded1949
CEOGeoffrey Martha
Employees90,000
Stock ExchangeNYSE
Ticker SymbolMDT
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 28 analysts, the average rating for Medtronic plc. stock is "Buy." The 12-month stock price forecast is 131.64, which is an increase of 22.43% from the latest price.

Price Target
$131.64
(22.43% upside)
Analyst Consensus: Buy

News

Medtronic's (MDT) DTM SCS Endurance Therapy Study Data Positive

Medtronic's (MDT) DTM SCS endurance therapy offers meaningful clinical benefits by reducing pain, improving quality of life and offering meaningful device longevity for patients.

1 day ago - Zacks Investment Research

Medtronic's Spinal Cord Stimulation Therapy Shows Meaningful Pain Relief

Medtronic plc (NYSE: MDT) announced three-month results from an on-label, prospective, multi-center study of Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) pain therapy. The data sh...

4 days ago - Benzinga

Medtronic announces results showing meaningful pain relief using DTM™ Spinal Cord Stimulation endurance therapy

DTM™ SCS endurance therapy enables long-lasting recharge-free performance on Vanta™ and 5-minute recharge on Intellis™ neurostimulators DUBLIN, Jan. 14, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a...

4 days ago - PRNewsWire

1 Green Flag for Medtronic in 2022, and 1 Red Flag

When the stock price follows the action of the FDA, investors hope the news is good.

4 days ago - The Motley Fool

Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know

Medtronic (MDT) closed at $108.95 in the latest trading session, marking a +0.98% move from the prior day.

5 days ago - Zacks Investment Research

Medtronic (MDT) Gets MHLW Approval for Micra AV Sale in Japan

The Micra AV approval is likely to boost Medtronic's (MDT) Cardiac Rhythm Management business while delivering the benefits of leadless pacing in Japan.

6 days ago - Zacks Investment Research

Medtronic announces schedule for presentations at the 2022 North American Neuromodulation Society Meeting

Sessions will include DTM™ SCS endurance therapy 3-month outcomes for patients with chronic back and leg pain DUBLIN, Jan. 12, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcar...

6 days ago - PRNewsWire

Medtronic (MDT) to Buy Affera, Expand in Electrophysiology

Affera's full suite of solutions and technologies will complement Medtronic's (MDT) existing atrial and ventricular arrhythmia disease management portfolio.

1 week ago - Zacks Investment Research

Medtronic's Leadless Micra AV Pacing System Scores Approval In Japan

Japan's Ministry of Health, Labor, and Welfare has approved Medtronic plc's (NYSE: MDT) Micra AV Transcatheter Pacing System (TPS). The Company will launch the product this month.

1 week ago - Benzinga

Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System

DUBLIN, Jan. 10, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received approval from Japan's Ministry of Health, Labor and Welfare for ...

1 week ago - PRNewsWire

Medtronic's Evolut Pro TAVR Approved In China, Acquires Cardiac Arrhythmia Treatment Developer Affera

Medtronic Plc's (NYSE: MDT) CoreValve Evolut Pro TAVR system has received National Medical Products Administration approval in China. The approval marks the first Medtronic TAVR system approved in China...

1 week ago - Benzinga

Medtronic Announces Approval of the Evolut™ PRO TAVR System in China

First Medtronic TAVR system approved in China for patients with symptomatic severe aortic stenosis DUBLIN, Jan. 10, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technolog...

1 week ago - PRNewsWire

Medtronic to Acquire Affera

Acquisition to expand company's cardiac ablation portfolio, including first-time entry into mapping and navigation, within one of the fastest growing medtech markets DUBLIN, Jan. 10, 2022 /PRNewswire/ -...

1 week ago - PRNewsWire

3 Unstoppable Growth Stocks to Buy in 2022 and Beyond

Diversification is key in investing!

Other symbols:COST
1 week ago - The Motley Fool

What's Happening With Medtronic Stock?

The stock price of Medtronic has seen a fall of 4% over the last month, underperforming the broader indices, with the S&P 500 rising 2% over the same period. This underperformance can largely be attribu...

1 week ago - Forbes

2 Stocks That Could Set You Up for Life

Both of these stocks have lagged the market in the past year, but don't let that scare you away.

Other symbols:ABNB
1 week ago - The Motley Fool

Medtronic (MDT) Gains As Market Dips: What You Should Know

Medtronic (MDT) closed the most recent trading day at $106.39, moving +0.27% from the previous trading session.

1 week ago - Zacks Investment Research

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

DUBLIN, Jan. 4, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate virtually in the 40th annual J.P. Morgan healthcare conferen...

2 weeks ago - PRNewsWire

Titan Medical Completes Final Milestone Under Development Agreement with Medtronic

TORONTO--(BUSINESS WIRE)--Titan Medical Completes Final Milestone under Development Agreement with Medtronic

Other symbols:TMDI
2 weeks ago - Business Wire

Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know

Medtronic (MDT) closed the most recent trading day at $103.95, moving -0.55% from the previous trading session.

2 weeks ago - Zacks Investment Research

Should You Buy This Beaten-Down Blue-Chip Stock?

Medtronic's stock has significantly lagged the S&P 500 this year for a variety of reasons.

3 weeks ago - The Motley Fool

7 Stock Bargains Worth a Look After the Most Recent Pullback

Value investors may choose to buy stocks that are out of favor and from among beaten up stock bargains in a variety of sectors. The post 7 Stock Bargains Worth a Look After the Most Recent Pullback appe...

3 weeks ago - InvestorPlace

Medtronic (MDT) to Gain From Expanded Medicare Coverage for CGM

CMS' expanded Medicare coverage includes continuous glucose monitors that can be integrated with Medtronic's (MDT) insulin pumps.

3 weeks ago - Zacks Investment Research

Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?

3 weeks ago - Zacks Investment Research

4 Internet of Medical Things (IoMT) Stocks to Buy for 2022

Stocks like Boston Scientific (BSX), Medtronic (MDT), DexCom (DXCM) and Syneos Health (SYNH) are evolving rapidly in the field of IoMT.

Other symbols:BSXDXCMSYNH
3 weeks ago - Zacks Investment Research